首页> 外国专利> Procedures for preparing crystalline particles of fluticasone, beclomethasone, salmeterol salbutamol and.

Procedures for preparing crystalline particles of fluticasone, beclomethasone, salmeterol salbutamol and.

机译:制备氟替卡松,倍氯米松,沙美特罗沙丁胺醇的晶体颗粒的程序。

摘要

A process for preparing crystalline particles of substance which is a pharmaceutical selected from fluticasone, beclomethasone, salmeterol, salbutamol or an ester, salt or solvate thereof which comprises mixing a solution of the substance in a liquid solvent with a liquid antisolvent for said substance which is liquid antisolvent miscible with the liquid solvent, characterized in that the resultant crystalline particles generated are harvested by a process which comprises: (i) mixing a first liquid phase formed from the resultant suspension of substance crystalline solvent / antisolvent mixture with a third liquid which is immiscible with said solvent / anti-solvent mixture or a component thereof thereby forming a second liquid phase and which is a non-solvent for the substance such that the substance it is segregated into the second liquid phase; (Ii) separating the two phases; and (iii) separating the crystalline particles of substance from the second liquid phase.
机译:制备物质的结晶颗粒的方法,该物质是选自氟替卡松,倍氯米松,沙美特罗,沙丁胺醇或其酯,盐或溶剂化物的药物,该方法包括将该物质在液体溶剂中的溶液与用于该物质的液体抗溶剂混合与液体溶剂可混溶的液体反溶剂,其特征在于,所产生的结晶颗粒是通过以下方法收集的:(i)将由所得物质结晶溶剂/反溶剂混合物的悬浮液形成的第一液相与第三液体相混合。与所述溶剂/反溶剂混合物或其组分不混溶,从而形成第二液相,并且对于所述物质而言是非溶剂,使得所述物质被分离成第二液相; (ii)将两个阶段分开; (iii)从第二液相中分离出物质的结晶颗粒。

著录项

  • 公开/公告号ES2258156T3

    专利类型

  • 公开/公告日2006-08-16

    原文格式PDF

  • 申请/专利权人 GLAXO GROUP LIMITED;

    申请/专利号ES20020770107T

  • 发明设计人 MCLOUGHLIN MARTIN JOHN;

    申请日2002-10-23

  • 分类号A61K9/14;

  • 国家 ES

  • 入库时间 2022-08-21 21:35:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号